Menu Search
Equities

Coltene Holding AG

M3Z:BRN

Coltene Holding AG

Actions
  • Price (CHF)51.57
  • Today's Change0.00 / 0.00%
  • Shares traded210.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 07 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Coltene Holding AG is a Switzerland-based Company active in the healthcare sector. It develops, manufactures and sells dental consumables and small equipment focusing on mechanical instruments and filling materials. It has production facilities in Switzerland, the United States, Germany and Hungary. The Company's product range comprises six product groups: Adhesives / Restoratives; Endodontics; Prosthetics; Rotary Instruments; Treatment Auxiliaries; and Hygiene. Coltene Holding AG has a number of wholly owned subsidiaries active in production and sales of dental specialties based in Switzerland, Germany, Hungary, Canada, the United Kingdom, France, China, India, the United States and Brazil.

  • Revenue in CHF (TTM)242.73m
  • Net income in CHF11.95m
  • Incorporated2005
  • Employees1.20k
  • Location
    Coltene Holding AGFeldwiesenstrasse 20ALTSTAETTEN 9450SwitzerlandCHE
  • Phone+41 717575380
  • Fax+41 717575301
  • Websitehttps://www.coltene.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.